“METABOLIC AND CARDIOVASCULAR RISKS OF SECOND-GENERATION ANTIPSYCHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF WEIGHT GAIN, DYSLIPIDEMIA, HYPERGLYCEMIA, AND QTC PROLONGATION IN ADULTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER COMPARING OLANZAPINE, RISPERIDONE, QUETIAPINE, AND ARIPIPRAZOLE”, FMHR, vol. 4, no. 3, pp. 599–610, Mar. 2026, Accessed: Aug. 04, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/2481